Randomized aldactone evaluation study (RALES) showed that adding aldosterone antagonist in the treatment of heart failure may decrease 30% mortality of all causes.

随机螺内酯评估研究表明在心力衰用醛甾酮拮抗药可使总死亡率降低30%。